Pearls and Oy-sters: Acute ischemic stroke caused by atypical thrombotic thrombocytopenic purpura

Neurology

Volumn 80, Issue 22, 2013, Pages

  Rojas, Julio C ^a   Banerjee, Chirantan ^a   Siddiqui, Fazeel ^a   Nourbakhsh, Bardia ^a   Powell, Craig M ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOSPORIN; HEPARIN; PREDNISONE; RITUXIMAB; ROSUVASTATIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ANXIETY; APHASIA; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CEREBROVASCULAR ACCIDENT; DIFFUSION WEIGHTED IMAGING; DRUG WITHDRAWAL; DYSARTHRIA; FEMALE; HEMIPARESIS; HUMAN; HYPERTENSION; LABORATORY TEST; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PLASMAPHERESIS; PRIORITY JOURNAL; TACHYCARDIA; THORAX PAIN; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WEAKNESS;

ADULT; BRAIN ISCHEMIA; FEMALE; HUMANS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; STROKE;

EID: 84879496344     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318294b423     Document Type: Article

References (10)

1. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura: Canadian Apheresis Study Group. N Engl J Med 1991;325:393-397.
2. Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine 1966;45:139-159.
3. Downes KA, Yomtovian R, Tsai HM, Silver B, Rutherford C, Sarode R. Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident. J Clin Apher 2004;19:86-89.
4. Idowu M, Reddy P. Atypical thrombotic thrombocytopenic purpura in a middle-aged woman who presented with a recurrent stroke. Am J Hematol Epub 2012 Apr. 26.
5. O'Brien TE, Crum ED. Atypical presentations of thrombotic thrombocytopenic purpura. Int J Hematol 2002;76:471-473.
6. Sevy A, Doche E, Squarcioni C, et al. Stroke in a young patient treated by alteplase heralding an acquired thrombotic thrombocytopenic purpura. J Clin Apher 2011;26:152-155.
7. Tsai HM, Shulman K. Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura. Eur J Haematol 2003;70:183-185.
8. Sarode R. Atypical presentations of thrombotic thrombocytopenic purpura: a review. J Clin Apher 2009;24:47-52.
9. Ono T, Mimuro J, Madoiwa S, et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood 2006;107:528-534.
10. Amann K. ADAMTS13: more than just TMA and TTP. Nephrol Dial Transpl 2011;26:1761-1764.